Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
OCRA Rivkin Family SummeRun Brings Together Nearly 1,000 Participants for a Day of Hope and Progress for Ovarian Cancer Research
Nearly 1,000 runners, walkers, survivors, families, friends, and supporters gathered at Seattle’s Seward Park on Sunday, July 12, 2026, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun. This year’s event raised close to $250,000. Now in its 33rd year, the event once again transformed the park into a sea of teal and purple, … Continued
OCRA Rivkin Family SummeRun Returns July 12 to Honor a Lasting Legacy and Fund Ovarian Cancer Research
SEATTLE, WA, July 9, 2026 — Nearly 1,000 runners, walkers, survivors, families, friends, and supporters are expected to gather at Seward Park on Sunday, July 12, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, one of the nation’s longest-running events dedicated to funding ovarian cancer research. Participants of all ages and abilities will transform … Continued
The Overview: June 2026
Nearly 500 people have already registered for OCRA’s International Gynecologic Cancer Conference®—the largest conference dedicated to the gynecologic cancer community—taking place on September 16–17. The conference is free, online, and open to all, and will include programming for ovarian, endometrial, cervical, and rare gynecologic cancers. For the first time, each of these diseases will have a dedicated Ask the Experts session. Learn … Continued
